Health Blueprint

Back to Longevity News

News summary

GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration

Source: PR Newswire • Published: 13 Oct 2026, 00:15

Summarized by Masters of Longevity from PR Newswire.

A news article previewing a corporate partnership announcement about expanding joint clinical-trial services and regional collaboration across North America and APAC.

GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration
Key Takeaways
  • GCCL and LabConnect signed a Memorandum of Understanding to expand global clinical trial collaboration.
  • The agreement targets linking regional capabilities across North America and the Asia-Pacific to improve operational efficiency.
  • Planned initiatives include joint sales, integrated central lab services, shared systems, and coordinated project management.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCan Exergaming Improve Balance? What Older Adults Should KnowMotion-controlled games may make balance practice easier to repeat. The evidence supports a structured adjunct—not a fall-proofing shortcut.MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.